WeVote
Log In

Bill

Bill

HB 1123

Pharmacy benefit managers and pharmacy services administrative organizations; provide certain regulations for.

2025 Regular Session Introduced by Jansen Owen and 1 co-sponsor

Mississippi bill regulating pharmacy benefit managers' practices died in conference; aimed to increase transparency and control over prescription drug pricing intermediaries.

Died In Conference
#publichealthandwelfare #stateaffairs
0
WeVote Research Nonpartisan
Bill Summary · HB 1123

Legislative bill overview

HB 1123 sought to impose new regulatory requirements on pharmacy benefit managers (PBMs) and pharmacy services administrative organizations (PSAOs) operating in Mississippi. The bill aimed to increase transparency and control over how these intermediaries manage prescription drug benefits and negotiate with pharmacies.

Why is this important

PBMs and PSAOs significantly influence drug prices, pharmacy reimbursement rates, and patient access to medications. Regulating them could affect prescription drug costs for consumers, the viability of independent pharmacies, and insurance premiums—making this a issue touching healthcare affordability and market competition.

Potential points of contention

  • Industry opposition: PBMs represent major healthcare corporations that would resist regulations limiting their business practices and profit margins
  • Federal jurisdiction questions: PBMs are heavily regulated at the federal level under ERISA; state-level regulation may create conflicts or duplicative requirements
  • Unintended consequences: Strict regulations could increase administrative costs, potentially raising drug prices or reducing pharmacy participation in insurance networks

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.